-
June 13, 2018 Lupin launches generic Tobramycin Inhalation Solution USP in the US
-
June 4, 2018 Lupin launches generic Methylergonovine Maleate Tabs USP in the US
-
June 4, 2018 Lupin receives FDA approval for generic Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1mg/gram
-
May 31, 2018 Lupin launches Solosec™ (secnidazole) 2g Oral Granules in the US
-
May 31, 2018 Lupin appoints Nicholas Hart as President – Specialty for US Business
-
May 25, 2018 Lupin submits Marketing Authorization Application for Etanercept Biosimilar in Europe
-
May 15, 2018 Lupin announces fiscal year 2018 Results, Board recommends dividend of 250%
-
May 14, 2018 Lupin’s Nagpur facility US FDA inspection concluded with no observations
-
May 10, 2018 Lupin launches Corcal Bone and Beauty supplement
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications